explore -WSS

explore

author：leisure time 2025-10-01 01:50:04 - browse：251

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Medicare Advantage's lean provider networks lead CMS complaints

entertainment

WSS

FTC loses bid to block Novant's North Carolina hospital merger

Sutter Health’s antitrust win overturned by appeals court

Data don't support strong claims for Covid

Illumina board agrees to spin off Grail, as divestment plans proceed

Sutter Health’s antitrust win overturned by appeals court

Stopping antidepressants leads to symptoms for 1 in 6 patients

focus

explore

focus

Activists slam private health insurers over coverage restrictions

10 million people disenrolled from Medicaid over past six months

At least 13 dead in Texas as scorching temps continue

Structure Therapeutics oral GLP

Medical leaders decry Supreme Court decision on affirmative action

Congress needs to close a vaccine

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ASCO Takeaways: Winners, snoozers, and the art of cancer care

At least 13 dead in Texas as scorching temps continue

Data don't support strong claims for Covid

entertainment

Finland to offer bird flu vaccine to select groups of people, a possible global first

FTC loses bid to block Novant's North Carolina hospital merger

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

10 million people disenrolled from Medicaid over past six months

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Wikipedia

hotspot

entertainment

leisure time